Cost-effectiveness of rapid tests and other existing strategies for screening and management of early-onset group B streptococcus during labour

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 13, 2010, Pages 1616-1627

  Kaambwa, B ^a   Bryan, S ^b   Gray, J ^c   Milner, P ^c   Daniels, J ^a   Khan, K S ^d   Roberts, T E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cost effectiveness; group B streptococcus; labour; rapid tests

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; COST EFFECTIVENESS ANALYSIS; DECISION TREE; FEMALE; GROUP B STREPTOCOCCAL INFECTION; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; LABOR; MAJOR CLINICAL STUDY; NEWBORN INFECTION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST;

ANTI-BACTERIAL AGENTS; COST-BENEFIT ANALYSIS; DECISION TREES; EARLY DIAGNOSIS; FEMALE; HUMANS; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; QUALITY-ADJUSTED LIFE YEARS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 78649262518     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02752.x     Document Type: Article

References (40)

1. Moore MR, Schrag SJ, Schuchat A,. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003; 3: 201 - 13.
2. Heath PT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, Tighe H, et al. Group B streptococcal disease in UK and Irish infants younger than 90days. Lancet 2004; 363: 292 - 4.
3. Zangwill KM, Schuchat A, Wenger JD,. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 1992; 41: 25 - 32.
4. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. MMWR 2002; 51: 1 - 18.
5. Baker CJ, Edwards MS,. Group B streptococcal infections. In:, Remington J, Klein JO, editors. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders; 1990. pp. 742 - 811.
6. Colbourn T, Gilbert R,. An overview of the natural history of early onset group B streptococcal disease in the UK. Early Hum Dev 2007; 83: 149 - 56.
7. Colbourn TE, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, et al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ 2007; 335: 655.
8. Oddie S, Embleton ND,. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002; 325: 308.
9. Schroeder EA, Petrou S, Balfour G, Edamma O, Heath PT,. The economic costs of group B streptococcus (GBS) disease: prospective cohort study of infants with GBS disease in England. Eur J Health Econ 2009; 10: 275 - 85.
10. Benitz WE, Gould JB, Druzin ML,. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999; 103: e77.
11. Daniels J, Gray J, Pattison H, Roberts TE, Edwards E, Milner P, et al. Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 2009; 13: 1 - 154, iii- iv.
12. Smaill F,. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database Syst Rev 1996; 1: CD000115.
13. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15 - 20.
14. Royal College of Obstetrics and Gynaecology. Prevention of Early Onset Neonatal Group B Streptococcal Disease. London: Royal College of Obstetrics and Gynaecology, 2003. Guideline No. 36.
15. Health Protection Agency. Interim 'Good Practice' Recommendations for the Prevention of Early Onset Neonatal Group B Streptococcal (GBS) Infections in the UK. London: Health Protection Agency, 2004.
16. Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess 2007; 11: 1 - 226, iii.
17. Goddard KA, Townsend R, Ridgway E,. Rapid diagnosis of intrapartum group B streptococcal carriage by fluorescent in situ hybridisation. J Clin Pathol 2007; 60: 842 - 3.
18. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360: 2626 - 36.
19. Honest H, Sharma S, Khan KS,. Rapid tests for group B Streptococcus colonization in laboring women: a systematic review. Pediatrics 2006; 117: 1055 - 66.
20. Barton P, Bryan S, Robinson S,. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy 2004; 9: 110 - 8.
21. DATA Treeage. Williamstown, MA: TreeAge Software Inc, 2005.
22. Ramus RM, McIntire DD, Wendel GD Jr,. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term. Am J Obstet Gynecol 1999; 180 (Suppl. 1): S85.
23. Office of National Statistics. Preterm births. England and Wales. 2007 []. Last accessed 24 June 2008.
24. Weisner AM, Johnson AP, Lamagni TL, Arnold E, Warner M, Heath PT, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infect Dis 2004; 38: 1203 - 8.
25. NHS. NHS pay - agenda for change - pay rates. 2007 []. Last accessed 25 June 2008.
26. Unit of Costs of Health and Social Care., Curtis L, Netten A,. editors. Canterbury: Personal Social Services Research Unit, The University of Kent, 2006.
27. Department of Health. NHS Reference costs 2006-07 collection: costing and activity guidance and requirements. 2007 []. Last Accessed 25 June 2008.
28. British National Formulary. British National Formulary. 2007. []. Last accessed 25 June 2008.
29. National Institute for Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal. London: NICE, 2004.
30. Andronis L, Barton P, Bryan S,. Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health Technol Assess 2009; 13:iii, ix 1 - 61.
31. Drummond MF, Sculpher MJ, O'Brien B, Stoddart GL, Torrance GW,. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press, 2005.
32. Government Actuary's Department. Interim life tables. []. Last accessed 25 June 2008.
33. Cantor SB,. Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment. Med Decis Making 1994; 14: 259 - 65.
34. Gold MR, Siegel JE, Russell LB, Weinstein MC,. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
35. Ohlsson A, Shah VS,. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database Syst Rev 2009;(3): CD007467. DOI:.
36. Culyer A, McCabe C, Briggs A, Claxton K, Buxton M, Akehurst R, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy 2007; 12: 56 - 8.
37. Cromwell D, Joffe T, Van Der Meulen J, Dhillon C, Hughes R, Murphy D,. The Prevention of Early-Onset Neonatal Group B Streptococcal Disease in UK Obstetric Units: A Audit of Reported Practice in England, Scotland, Wales and Northern Ireland. London: Royal College of Obstetrics and Gynaecology, 2007.
38. Greenland S, Salvan A,. Bias in the one-step method for pooling study results. Stat Med 1990; 9: 247 - 52.
39. Bradburn MJ, Deeks JJ, Berlin JA, Russell LA,. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med 2007; 26: 53 - 77.
40. El Helali N, Nguyen JC, Ly A, Giovangrandi Y, Trinquart L,. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis 2009; 49: 417 - 23.